EnXray Limited

EnXray Limited specializes in advanced imaging solutions for healthcare, particularly in radiology and diagnostic imaging, delivering innovative software that enhances the accuracy and efficiency of medical imaging processes. EnXray Limited, founded in 2012, operates from Liverpool, UK, providing advanced imaging solutions for healthcare. The company has undergone strategic pivots and completed a total of 3 deals, with their most recent funding round occurring on February 20, 2017, where they raised GBP 327,000. EnXray has a current valuation of GBP 6.

609 mn, reflecting its position in the healthcare imaging industry. EnXray specializes in advanced imaging solutions for healthcare, focusing primarily on radiology and diagnostic imaging. Their core product offerings include innovative imaging software designed to enhance the accuracy and efficiency of medical imaging processes. These solutions aim to address critical use cases such as improving diagnostic precision, streamlining workflow for radiologists, and facilitating better patient outcomes.

EnXray's technology is utilized by hospitals, radiology clinics, and imaging centers across North America and Europe, providing indispensable support to healthcare professionals. Their products have been released in various versions over the past few years, continually evolving to meet the demands of modern medical practices and regulatory standards. EnXray generates revenue through a combination of software subscriptions and direct sales of their imaging solutions to healthcare providers. The transaction structure typically involves long-term licensing agreements where clients pay for access to EnXray’s flagship imaging software, with additional fees for upgrades and technical support.

This model allows for predictable recurring revenue while also facilitating one-time sales of proprietary imaging tools. Specific pricing plans are tailored to the size and needs of healthcare facilities, ensuring that various client segments, from small clinics to large hospital networks, can benefit from their offerings. This strategic positioning in the market underscores EnXray's commitment to providing high-quality, reliable imaging solutions to their diverse customer base. EnXray plans to leverage its recent funding of GBP 327,000 from February 2017 to support the development of new imaging software products aimed at enhancing diagnostic capabilities in healthcare settings.

The company is also targeting expansion into new geographic markets across Europe and North America by 2025, focusing on regions with a growing demand for advanced imaging solutions. This strategic growth initiative reflects EnXray's commitment to addressing the evolving needs of healthcare providers and improving patient care outcomes.